Bristol Myers CVR Falls as FDA Jitters Overshadow Huge Potential

(Bloomberg) -- Bristol Myers Squibb Co.’s comments that U.S. regulators still haven’t planned to inspect a facility that makes one of its experimental cancer drugs overshadowed news that a filing f...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.